Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.

Show other versions (1)

BACKGROUND: The efficacy of RTS,S/AS01 as a vaccine for malaria is being tested in a phase 3 clinical trial. Early results show significant, albeit partial, protection against clinical malaria and severe malaria. To ascertain variations in vaccine efficacy according to covariates such as transmissio...

Full description

Bibliographic Details
Main Authors:	Bejon, P, White, M, Olotu, A, Bojang, K, Lusingu, J, Salim, N, Otsyula, N, Agnandji, S, Asante, K, Owusu-Agyei, S, Abdulla, S, Ghani, A
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data
by: Bejon, P, et al.
Published: (2013)

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
by: White, M, et al.
Published: (2014)

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.
by: Warimwe, G, et al.
Published: (2013)

THE RTS,S MALARIA VACCINE What is the efficacy of the RTS,S malaria vaccine?
by: Duncan, C, et al.
Published: (2011)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
by: Olotu, A, et al.
Published: (2016)

What is the efficacy of the RTS,S malaria vaccine?
by: Duncan, C, et al.
Published: (2011)

What is the efficacy of the RTS,S malaria vaccine?
by: Duncan, C, et al.
Published: (2011)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
by: Bejon, P, et al.
Published: (2008)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
by: Olotu, A, et al.
Published: (2010)

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
by: Olotu, A, et al.
Published: (2013)

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection
by: White, M, et al.
Published: (2013)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children
by: Olotu, A, et al.
Published: (2014)

PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
by: Bejon, P, et al.
Published: (2008)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
by: Bejon, P, et al.
Published: (2009)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
by: Agnandji, S, et al.
Published: (2012)

Response to "Poor control vaccines in two randomised trials of malaria vaccine?".
by: Bejon, P, et al.
Published: (2009)

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
by: Agnandji, S, et al.
Published: (2011)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.
by: Lievens, M, et al.
Published: (2011)

Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
by: Agnandji, S, et al.
Published: (2014)

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
by: Bejon, P, et al.
Published: (2011)

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
by: Otieno, L, et al.
Published: (2019)

RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype
by: Nielsen, C, et al.
Published: (2018)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
by: Lusingu, J, et al.
Published: (2010)

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
by: Guerra Mendoza, Y, et al.
Published: (2019)

RTS,S/AS01 malaria vaccine in African children.
by: Hill, A
Published: (2012)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
by: Olotu, A, et al.
Published: (2011)

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
by: Olotu, A, et al.
Published: (2011)

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial
by: Olotu, A, et al.
Published: (2011)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.
by: Vekemans, J, et al.
Published: (2011)

Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP
by: Rampling, T, et al.
Published: (2016)

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E
by: Ndungu, F, et al.
Published: (2012)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
by: Horowitz, A, et al.
Published: (2012)

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
by: Gosling, R, et al.
Published: (2015)

Safety and Efficacy of Novel Malaria Vaccine Regimens of RTS,S/AS01B alone, or with Concomitant ChAd63-MVA Vectored Vaccines Expressing ME-TRAP
by: Rampling, T, et al.
Published: (2018)

CXCR3+ T follicular helper cells induced by co-administration of RTS,S/AS01B and viral vectored vaccines are associated with reduced immunogenicity and efficacy against Malaria
by: Ewer (nee Russell), K, et al.
Published: (2018)

Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa
by: Galactionova, K, et al.
Published: (2017)

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
by: Agnandji, S, et al.
Published: (2016)

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
by: Dunachie, S, et al.
Published: (2006)

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
by: Rampling, T, et al.
Published: (2016)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children
by: Ndungu, F, et al.
Published: (2019)